Main Article Content
Background: Pre-eclampsia (PE) is a pregnancy associated pro-inflammatory disorder. The only known treatment is to deliver the placenta and fetus. PE is clinically identified by hypertension and proteinuria post-20th week of gestation. Early onset pre-eclampsia (EOPE), a severe form of PE is defined as when the clinical symptoms are observed before 34 weeks of gestation. There are no definite biomarkers available for early diagnosis of EOPE. Human dendritic cell (DC) subsets (CD1c+, CD141+ myeloid DCs and plasmacytoid DCs) are intricately involved with the process of inflammation and are significantly altered (quantitatively and functionally) in several proinflammatory disorders. These changes offer value for monitoring DC subsets as potential biomarker(s) and as targets for immunotherapeutic treatment. DC subsets play a critical role in normal pregnancy by mediating efficient migration and invasion of trophoblasts and maintaining anti-inflammatory environment of immunotolerance. In contrast, the status of DC subsets in the proinflammatory microenvironment of EOPE pregnancy requires thorough evaluation. In this direction, the designed study protocol aims to understand how DC subsets are altered (quantitatively and functionally) in EOPE patients, compared to normal pregnant women.
Methods: Study is observational, designed to determine changes in the profile of DC subsets in the blood and decidua of EOPE diagnosed patients (n=30) by multiparametric flow cytometry approach. Normal pregnant women (n=30) are included as controls.
Results: The study participants enrolment started in December 2020 and this study protocol describes the methodology being employed.
Discussion: Human DC subsets are altered both quantitatively and functionally in the pro-inflammatory microenvironment. EOPE is a pro-inflammatory disorder and changes in the composition and function of DC subsets in these patients, compared to normal pregnant women is unclear. Understanding changes in the profile of DC subsets in blood samples from EOPE patients will provide the foundation for identification of potential biomarkers. Similarly, changes in the profile of DC subsets in the decidua of EOPE patients will provide the basis for developing novel immunotherapeutic strategies targeting distinct DC subsets or their products for the treatment of EOPE. Overall, the current study protocol and subsequent findings will help develop future large scale, prospective design clinical trials focussing on formulating strategies for early diagnosis and treatment of EOPE among pregnant women.
O'Tierney-Ginn PF, Lash GE. Beyond pregnancy: Modulation of trophoblast invasion and its consequences for fetal growth and long-term children's health. J Reprod Immunol. 2014;104-105:37-42.
Gathiram P, Moodley J, Pre-eclampsia: Its pathogenesis and pathophysiolgy. Cardiovascular Journal of Africa. 2016;27(2):71-78.
Dymara-Konopka W, Laskowska M, Oleszczuk J. Preeclampsia - Current management and future approach. Curr Pharm Biotechnol. 2018;19(10):786-796.
Staff AC, Redman CWG. The differences between early- and late-onset pre-eclampsia. In: Saito S. (eds) Preeclampsia. Comprehensive Gynecology and Obstetrics. Springer, Singapore; 2018.
Macri C, Pang ES, Patton T, O'Keeffe M. Dendritic cell subsets. Semin Cell Dev Biol. 2018;84:11-21.
Amodio G, Gregori S. Dendritic cells a double-edge sword in autoimmune responses. Front Immunol. 2012;3:233.
Saadeh D, Kurban M, Abbas O. Update on the role of plasmacytoid dendritic cells in inflammatory/autoimmune skin diseases. Exp Dermatol. 2016;25(6): 415-21.
Ortega Moreno L, Fernández-Tomé S, Chaparro M, Marin AC, Mora-Gutiérrez I, Santander C, et al. Profiling of human circulating dendritic cells and monocyte subsets discriminates between type and mucosal status in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2020:151.
Galati D, Zanotta S, Corazzelli G, Bruzzese D, Capobianco G, Morelli E, et al. Circulating dendritic cells deficiencies as a new biomarker in classical Hodgkin lymphoma. Br J Haematol. 2019;184(4):594-604.
Kim SH, Jung HH, Lee CK. Generation, characteristics and clinical trials of ex vivo generated tolerogenic dendritic cells. Yonsei Med J. 2018;59(7):807-815.
Blanco P, Palucka AK, Pascual V, Banchereau J. Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev. 2008;19(1):41-52.
Ban YL, et al. BDCA-1+, BDCA-2+ and BDCA-3+ dendritic cells in early human pregnancy decidua. Clin Exp Immunol. 2008;151(3):399-406.
Ueda Y, et al. Frequencies of dendritic cells (myeloid DC and plasmacytoid DC) and their ratio reduced in pregnant women: comparison with umbilical cord blood and normal healthy adults. Hum Immunol. 2003;64(12):1144-51.
Yu CI, Becker C, Metang P, Marches F, Wang Y, Toshiyuki H, et al. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J Immunol. 2014;193(9):4335-43.
Yeh CC, Chao KC, Huang SJ. Innate immunity, decidual cells, and preeclampsia. Reprod Sci. 2013;20(4):339-53.
Huang SJ, et al. Pre-eclampsia is associated with dendritic cell recruitment into the uterine decidua. J Pathol. 2008;214(3):328-36.
Huang SJ, et al. The implication of aberrant GM-CSF expression in decidual cells in the pathogenesis of preeclampsia. Am J Pathol. 2010;177(5):2472-82.
Hu YL, et al. Changes in the ratio of Tc1/Tc2 and Th1/Th2 cells but not in subtypes of NK-cells in preeclampsia. International Journal of Molecular Sciences. 2007;8(6):492-504.
Hs P, et al. Altered decidual DC-SIGN+ antigen-presenting cells and impaired regulatory T-cell induction in preeclampsia. Am J Pathol. 2012;181(6):2149-60.
Zhang W, Zhou Y, Ding YL. Lnc-DC mediates the over-maturation of decidual dendritic cells and induces the increase in Th1 cells in preeclampsia. American Journal of Reproductive Immunology. 2017;77(6).
Wang J, et al. Dendritic cells derived from preeclampsia patients influence Th1/Th17 cell differentiation in vitro. Int J Clin Exp Med. 2014;7(12):5303-9.
Panda B, et al. Dendritic cells in the circulation of women with preeclampsia demonstrate a pro-inflammatory bias secondary to dysregulation of TLR receptors. J Reprod Immunol. 2012;94(2): 210-5.
Tandberg A, Klungsøyr K, Romundstad LB, Skjærven R. Pre-eclampsia and assisted reproductive technologies: Consequences of advanced maternal age, interbirth intervals, new partner and smoking habits. BJOG. 2015;122(7):915-22.
Riesche L, Bartolomei MS. Assisted reproductive technologies and the placenta: Clinical, morphological, and molecular outcomes. Semin Reprod Med. 2018;36(3-04):240-248.
Luo ZC, An N, Xu HR, Larante A, Audibert F, Fraser WD. The effects and mechanisms of primiparity on the risk of pre-eclampsia: a systematic review. Paediatr Perinat Epidemiol. 2007;211:36-45.
Technical guidelines issued by central pollution control board (CPCB) for handling biowaste.
Technical guidelines issued by gujarat pollution control board (GPCB) for handling biowaste.
Della Bella S, et al. Incomplete activation of peripheral blood dendritic cells during healthy human pregnancy. Clin Exp Immunol. 2011;164(2):180-92.
Autissier P, et al. Evaluation of a 12-color flow cytometry panel to study lymphocyte, monocyte, and dendritic cell subsets in humans. Cytometry A. 2010;77(5):410-9.
Shin S, et al. Differences in circulating dendritic cell subtypes in pregnant women, cord blood and healthy adult women. J Korean Med Sci. 2009;24(5):853-9.
Aldebert D, et al. Differences in circulating dendritic cell subtypes in peripheral, placental and cord blood in African pregnant women. J Reprod Immunol. 2007;73(1):11-9.
Almeida J, et al. Extensive characterization of the immunophenotype and pattern of cytokine production by distinct subpopulations of normal human peripheral blood MHC II+/lineage- cells. Clin Exp Immunol. 1999;118(3):392-401.
Della Bella S, et al. Application of six-color flow cytometry for the assessment of dendritic cell responses in whole blood assays. J Immunol Methods. 2008;339(2):153-64.
De Paoli P, et al. Enumeration of human lymphocyte subsets by monoclonal antibodies and flow cytometry: A comparative study using whole blood or mononuclear cells separated by density gradient centrifugation. J Immunol Methods. 1984;72(2):349-53.
Ashmore LM, Shopp GM, Edwards BS. Lymphocyte subset analysis by flow cytometry. Comparison of three different staining techniques and effects of blood storage. J Immunol Methods. 1989;118(2):209-15.
Romeu MA, et al. Lymphocyte immunophenotyping by flow cytometry in normal adults. Comparison of fresh whole blood lysis technique, Ficoll- Paque separation and cryopreservation. J Immunol Methods. 1992;154(1):7-10.
Landay AL, Muirhead KA. Procedural guidelines for performing immunophenotyping by flow cytometry. Clin Immunol Immunopathol. 1989;52(1):48-60.
Ristich V, Liang S, Zhang W, Wu J, Horuzsko A. Tolerization of dendritic cells by HLA-G. Eur J Immunol. 2005;35(4):1133-42.
Collin M, Bigley V. Human dendritic cell subsets: an update. Immunology. 2018;154(1):3-20.
Male V, Gardner L, Moffett A. Isolation of cells from the feto-maternal interface. Curr Protoc Immunol. 2012;7(7):40 1-11.
Xu Yi, et al. Isolation of leukocytes from the human-maternal interface. Journal of Visualized Experiments. 2015;(99):52863.
Dagur PK, McCoy JP. Jr., collection, storage, and preparation of human blood cells. Curr Protoc Cytom. 2015;73(5): 1:1-16.
MacDonald KP, et al. Characterization of human blood dendritic cell subsets. Blood. 2002;100(13):4512-20.
Liu S, Diao L, Huang C, Li Y, Zeng Y, Kwak-Kim JYH. The role of decidual immune cells on human pregnancy. J Reprod Immunol. 2017;124:44-53.
Cappelletti M, Giannelli S, Martinelli A, Cetin I, Colombo E, Calcaterra F, et al. Lack of activation of peripheral blood dendritic cells in human pregnancies complicated by intrauterine growth restriction. Placenta. 2013;34(1): 35-41.